Reading this on a mobile device? Try our optimized mobile version here:

November 15, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  • Injectable sponges can deliver drugs, stem cells
    Researchers at Harvard University have developed an injectable, compressible gel-based sponge that can release drugs and stem cells into the body. After injection, the sponge goes back to its original size, then disintegrates. The sponge has potential uses in transplanting stem cells for tissue regeneration or in delivering immune cells, a researcher said. The team's findings were published in the Proceedings of the National Academy of Sciences. Yahoo/Asian News International (11/14) LinkedInFacebookTwitterEmail this Story
Announcing the Arrival of FMH RapidScreen
The new FMH RapidScreen offers a faster more simplified feto-maternal hemorrhage screening test to give you peace of mind in generating a quick result for the protection of mothers and their newborns. FMH RapidScreen provides up to 35% decrease in total test time compared to other marketed tests. To learn more about this product, call us at 855-IMMUCOR or visit our website.

  Science & Health 
  • Updated study finds positive effects for dabigatran
    A 2.3-year extension of the RE-LY study found that patients with atrial fibrillation who took the anticoagulant dabigatran for the extension period continued to do well in terms of strokes and major bleeding events. The extension involved 5,851 patients who remained on either a 150-milligram or 110-milligram dose. Each dose was linked to very low rates of hemorrhagic stroke, while the 150-milligram dose was tied to fewer ischemic strokes but more major bleeding than the lower dose. Medscape (free registration) (11/13) LinkedInFacebookTwitterEmail this Story
  • Pancreatic stem cells show promise for type 1 diabetes
    Australian researchers have identified pancreatic stem cells that can be converted into insulin-producing cells and found that the cells' number and capacity to become insulin-producers also appeared to increase in response to pancreatic damage. The findings in PLoS ONE may pave the way for new type 1 diabetes treatments, researchers said. Medical News Today (11/14) LinkedInFacebookTwitterEmail this Story
  • Advanced genome sequencing helps scientists stop MRSA outbreak
    Researchers stopped an outbreak of methicillin-resistant Staphylococcus aureus superbug in a hospital pediatric ward through fast genome-sequencing technology. They identified a hospital worker as the source of the outbreak after performing the technique on 12 patients with the MRSA strain and all the hospital's 154 staff. "This technology holds great promise for the quick and accurate identification of bacterial transmissions in our hospitals and could lead to a paradigm shift in how we manage infection control and practice," said Julian Parkhill, who worked on the study. Reuters (11/13) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • N.Y. clinicians use online app for disaster response
    After the recent superstorm, the staff at Mount Sinai Medical Center updated the family members of patients evacuated to the facility through an online application developed by MDconnectME. The app, originally designed to enable surgeons in the operating room to send quick updates and pre-filled messages to a list of recipients provided by patients, is being tested by the firm for other uses, including in the realm of the patient-centered medical home. (11/13) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • T2 secures 2 additional patents for rapid diagnostic device
    T2 Biosystems has secured two additional patents covering its T2MR diagnostic tool, which President and CEO John McDonough says can spot "anything" from certain DNA types to the blood's clotting ability in biological samples within a few hours. The company now has 16 global patents for the device, which will be tested for use in detecting Candida fungal blood infections. Mass High Tech (Boston) (11/14) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • FDA restricts U.S. import of Hospira's Symbiq infusion pumps
    Hospira has received an FDA notice restricting the importation into the U.S. of its Symbiq drug infusion systems, which are produced in Costa Rica. Hospira said the FDA restriction does not cover imports of its other drug management products. In October, the FDA said Hospira was recalling some Symbiq systems over software concerns. Reuters (11/14) LinkedInFacebookTwitterEmail this Story
  • FDA panel endorses Glaxo's avian flu vaccine
    The FDA's Vaccines and Related Biological Products Advisory Committee agreed unanimously to recommend approval of GlaxoSmithKline's Q-Pan H5N1 vaccine. Data from a Phase III trial revealed vaccine seroconversion rates exceeded the threshold for immunogenicity. (11/14) LinkedInFacebookTwitterEmail this Story
  Association News 
  • 6 scientists receive funding from 2012 NBF grants program
    The National Blood Foundation, or NBF, has awarded funding to six scientists from its 2012 scientific research grants program. The individuals have been awarded grants for one- or two-year research projects, with a maximum award of $75,000. Since 1985, the NBF has awarded approximately $7.5 million in grants to 177 scientific investigators to advance the field of transfusion medicine and cellular therapy. Read the news release. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
VP Patient ServicesBlood Centers of the PacificUS - CA - San Francisco
Quality Source ConsultantBlood Systems, Inc.US - Nationwide
Quality SpecialistBlood Systems, Inc.US - NM - Albuquerque
Immunohematology Reference TechnologistLifeStreamUS - CA - San Bernardino
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Help Desk SpecialistAABBUS - MD
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Staff AccountantAABBUS - MD
Click here to view more job listings.

Keep your fears to yourself but share your courage with others."
--Robert Louis Stevenson,
Scottish novelist, poet and essayist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information